About COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
"Misją Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli jest: Profesjonalne świadczenie pełnoprofilowych usług medycznych na rzecz Pacjenta Onkologicznego."
Clinical Trials at COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
During the past decade, COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 11 clinical trials were completed, i.e. on
average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej"
#1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
According to Clinical.Site data, the most researched conditions in "COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej" are
"Breast Cancer" (6 trials), "Early Breast Cancer" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Bladder Cancer" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej" in a lesser frequency.
Clinical Trials Intervention Types at COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
Most popular intervention types in "COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej" are "Drug" (15 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (6 trials), "Pertuzumab" (5 trials), "Atezolizumab" (4 trials), "Trastuzumab" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
The vast majority of trials in "COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej" are
10 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
Currently, there are NaN active trials in "COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".